The data on the ability of HSA to bind various compounds prompted us to undertake research on the use of HSA as a system capable of transporting peptidic inhibitors of insulin and amylin aggregation (both of these hormones are present in the amyloid deposits identified in people with diabetes). The gene discussed is ALB; the disease is diabetes mellitus.